期刊文献+

12-脂氧化酶对糖尿病肾病鼠肾小球p27^kap1表达的影响 被引量:1

Impact of 12-1ipoxygenase on p27^kap1 expression in experimental diabetic glomeruli
原文传递
导出
摘要 目的探讨12-脂氧化酶(12-LO)对糖尿病肾病肾小球内p27^kap1表达的影响。方法:在有或无p38MAPK(p38)抑制剂(SB203580,1μmol/L)的条件下,用12-LO作用产物12羟二十烷四烯酸[12(S)-HETE,10^-7mmol/L]刺激系膜细胞24h。雄性SD大鼠分为普通饮食对照组、普通饮食+12-L0抑制剂(CDC,8mg/kg,3次/周,皮下注射)处理组、高脂饮食结合小剂量链脲菌素(STZ,35mg/kg,腹腔注射)诱导2型糖尿病组、高脂饮食结合小剂量STZ诱导2型糖尿病+CDC处理组,连续皮下注射CDC1个月。野生型和12-LO基因敲除C57BL/6小鼠随机分成野生型对照组、12-L0基因敲除组、野生型STZ(200mg/kg,腹腔注射)诱导1型糖尿病组、12-LO基因敲除STZ诱导1型糖尿病组,饲养16周。实验结束后收集尿、血液、提取肾脏,用系列过筛方法分离肾小球。Western印迹和免疫组织化学方法检测p38活性和p27^kap1蛋白表达的变化。结果抑制p38活性可有效阻断12(S)-HETE诱导的系膜细胞内p27^kap1的表达(P〈0.01)。CDC可抑制2型糖尿病大鼠肾小球体积增大,降低尿白蛋白量(24h),阻止肾小球内p38活性和p27^kap1蛋白表达增加,与CDC未处理2型糖尿病大鼠比较差异均有统计学意义(均P〈0.01)。与野生型糖尿病小鼠比较,12-LO基因敲除糖尿病小鼠p38活性、p27^kap1蛋白表达及细胞外基质积聚显著减少,差异有统计学意义(均P〈0.01)。结论12-LO可通过p38通路上调糖尿病肾小球内p27^kap1的表达。 Objective To investigate the effect of 12-1ipoxygenase(12-LO) on the p27^kap1 expression in diabetic glomeruli. Methods Mesangia] cells were exposed to 12-LO product 12 (S)-HETE (10-7 mmol/L) with or without p38 MAPK (p38) inhibitor (SB203580, 1 μmol/L) for 24 hours. Rats fed with high fat diet received low dose streptozotoein (STZ, 35 mg/kg, IP injection) to develop type 2 diabetes and were divided into 2 groups: low dose STZ, low dose STZ+12-LO inhibitor einnamyl-3,4-dihydroxy-ct-cynanocinnamate (CDC, 8 mg/kg) treatment. Rats fed with regular chow were divided into two groups: controls, CDC treatment. The rats received injection of CDC or vehicle subcutaneously in the hind leg. CDC or vehicle injection was performed three times weekly on alternate days. All the rats were sacrificed after 4 weeks. Wild type and 12-LO knockout C57BL/6 mice were divided into 4 groups: wild type control, 12-LO knockout, STZ- induced wild type type 1 diabetes and STZ-induced 12-LO knockout type 1 diabetes. All the mice were sacrificed after 16 weeks. Urine, blood, kidney cortical tissue and isolated glomeruli by sieving method were collected at the end of study respectively. Western blot and immunohistochemistry for target protein were performed respectively. Results Inhibition of p38 activation could significantly reduce p27^kap1 expression induced by 12 (S)-HETE in mesangial ceils (P〈0.01). Increased glomerular volume, microalbuminuria, elevated glomeluli p38 activation, p27^kap1 expresssion in type 2 diabetic glomeruli was decreased after CDC treatment (P〈0.01). Compared with wild type diabetic mice, glomerular p38 activation, p27^kap1 expresssion and extracellular matrix accumulation in the 12-LO knockout diabetic mice were significantly decreased (P 〈0.01, respectively ). Conclusions 12-LO induces p27kipl expression via p38 pathway in diabetic glomeruli.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第5期381-386,共6页 Chinese Journal of Nephrology
基金 国家自然科学基金(30600288,30771007) 国家重点基础研究发展计划(2007CB507400) 吉林省杰出青年科研项目(20070131) 国家教育部留学回国人员科研启动基金(教外司留[2007]1108号)
关键词 脂氧合酶 糖尿病肾病 P38丝裂原活化蛋白激酶类 肾小球系膜 细胞 p27^kap1 肾小球 Lipoxygenase Diabetic nephropathies p38 mitogen-activated protein kinases Mesangial cells p27^kap1 Kidney glomerulus
  • 相关文献

参考文献17

  • 1George J, Afek A, Shaish A, et al. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor- deficient mice. Circulation, 2001, 104: 1646-1650.
  • 2Bleich D, Chen S, Zipser B, et al. Resistance to the type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest, 1999, 103: 1431-1436.
  • 3Xu ZG, Li SL, Lanting L, et al. Relationship between 12/ 15-1ipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Kidney Int, 2006, 69: 512- 519.
  • 4Reddy MA, Adler SG, Kim YS, et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol, 2002, 283: F985-F994.
  • 5Kim YS, Xu ZG, Reddy MA, et al. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol, 2005, 16:352-362.
  • 6Xu ZG, Yuan H, Lanting L, et al. Products of 12/15- lipoxygenase upregulate the angiotensin Ⅱ receptor. Kidney Int, 2006, 69: 512-519.
  • 7Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int, 1999, 56: 393-405.
  • 8Al-Douahji M, Brugarolas J, Brown PA, et al. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int, 1999, 56: 1691-1699.
  • 9Wolf G, Sehanze A, Stahl RAK, et al. p27^Kip1 knockout mice are protected from diabetic nephropathy:Evidence for p27^Kip1 haplotype insufficiency. Kidney Int, 2005, 68: 1583- 1589.
  • 10Wolf G, Schroeder R, Thaiss F, et al. Glomerular expression of p27^Kip1 in diabetic db/db mouse: role of hyperglycemia. Kidney Int, 1998, 53: 869-879.

二级参考文献7

  • 1Heilig CW,Liu Y,England RL,et al.D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells:implications for diabetic nephropathy.Diabetes,1997,46:1030-1039.
  • 2Heilig CW,Brosius FC,Cunningham C.Role for GLUT1 in diabetic glomerulosclerosis.Expert Rev Mol Med,2006,8:1-18.
  • 3Haneda M,Araki S,Togawa M,et al.Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions.Diabetes,1997,46:847-853.
  • 4Santalucia T,Sanchez-Feutrie M,Felkin LE,et al.Phenylephrine requires the TATA box to activate transcription of GLUT1 in neonatal rat cardiac myocytes.J Mol Cell Cardiol,2005,38:677-684.
  • 5Wolf G,Schanze A,Stahl RA,et al.p27Kip1 Knockout mice are protected from diabetic nephropathy:evidence for p27Kip1haplotype insufficiency.Kidney Int,2005,68:1583-1589.
  • 6Xu ZG,Yoo TH,Ryu DR,et al.Angiotensin Ⅱ receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.Kidney Int,2005,67:944-952.
  • 7李颖健,刘志红,刘栋,朱加明,郭啸华,黎磊石.葡萄糖转运蛋白1基因转染对系膜细胞功能的影响[J].中华肾脏病杂志,2000,16(6):357-362. 被引量:2

共引文献6

同被引文献24

  • 1许钟镐,孙晶,贾冶,苗里宁.12-脂氧化酶对系膜细胞血管紧张素Ⅱ1型受体表达的影响[J].中华肾脏病杂志,2006,22(10):628-631. 被引量:2
  • 2Kang SW,Adler SG,Nast CC,et al. 12-1ipoxygenase expression isincreased in diabetic nephropathy[J]. Kidney Int, 2001,59:1354.
  • 3Kang SW, Natarajan R, Shahed A, et al. Role of 12 lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose stimulated podocytes[J]. J Am Soc Nephrol, 2003, 14: 3178.
  • 4Xu ZG, Li SL, Lanting L, et al. Relationship between 12/15 li poxygenase and COX 2 in mesangial cells: Potential role in dia- betic nephropathy[J]. Kidney lnt, 2006,69 : 512.
  • 5Xu ZG,Miao LN,Cui YC,et al. Angiotensin II type 1 receptor expression is increased via 12-1ipoxygenase in high glucose s-timu- lated glomerular cells and type 2 diabetic glomeruli[J]. Nephrol Dial Transplant,2008,24 : 1744.
  • 6Xu ZG, Yuan H, Lanting L, et al. Products of 12/15-1ipoxygenase upregulate the angiotensin lI receptors[J]. J Am Soc Nephrol, 2008,19:559.
  • 7Guo QY, Miao LN, Xu ZG, et al. Role of 12-1ipoxygenase in de creasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular sizes in type 2 diabetic rats [J]. Am J Physiol Endocrinol Metab, 2011,300 : E708.
  • 8]Bleich D,Chen S,Zipser B,et al. Resistance to the type 1 diabe- tes induction in 12 lipoxygenase knockout mice[J]. J CI n In vest, 1999,103 : 1431.
  • 9Bleich D, Chen S, Gu JL, et al. The role of 12-1ipoxygenase in pancreatic-cells[J]. Int J Mol Med, 1998,1 :265.
  • 10Han X,Chen S,Sun Y,et al. Induction of cyclooxygenase-2 gene in pancreatic ?-cell by 12-1ipoxygenase pathway procluct 12- hydroxyeicosateraenoic acid[J]. Mol Endocrinol, 2002,16 : 2145.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部